Diagnosis and Management of Migraine
BMJ 312:1279-1283, Goadsby,P.J.&Olesen,J., 1996
Use and Eligibility for Glucose-Like Peptide-1 Receptor Agonist Treatment for Primary Preveention of Stroke
Neurol 104:e213739, Wilson,L.M. & Anderson,T.S., 2025
GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension
JAMA Neurol 82:887-892, Sioutas,G.S.,et al, 2025
New Treatments for Migraine: CGRP Monoclonal Antibodies, Gepants, and Ditans
BMJ 390:e085564, Burch, R. & Rittenberg, E., 2025
Idiopathic Intracranial Hypertension
NEJM 393:1409-1414, Horton,J.C., 2025
Comparative Effects of Drug Interventions for the Acute Management of Migraine Episodes in Adults:Systematic Review and Network Meta-Analysis
BMJ 386:e080107, Karlsson,W.K.,et al, 2024
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity
NEJM 391:1193-1205, Malhotra,A.,et al, 2024
Atogepant for the Preventive Treatment of Chronic Migraine (PROGRESS): A Randomised, Double-blind, Placebo-controlled, Phase 3 Trial
Lancet 402:775-785, Pozo-Rosich,P.,et al, 2023
Delayed Cerebral Abscess Formation after Posterior Cerebral Artery Stroke in a Patient with Opioid Use Disorder
Stroke 52:e100-e103, Zuflacht,J.P.& Fehnel,C.R., 2021
Acute Treatment for Migraine
JAMA 325:2346-2347, Burch, R. & Rayhill, M., 2021
Atogepant for the Preventive Treatment of Migraine
NEJM 385:695-706, Ailani,J.,et al, 2021
One-Year Sustained Efficacy of Erenumab in Episodic Migraine
Neurol 95:e469-e479, Goadsby, P.J.,et al, 2020
Migraine
NEJM 383:1866-1876, Ashina, M., 2020
Remigepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, for Migraine
NEJM 381:142-149, Lipton, R.B.,et al, 2019
Trial of Galcanezumab in Prevention of Episodic Cluster Headache
NEJM 381:132-141, Goadsby, P.J.,et al, 2019
Clinicopathologic Conference, Statin-Associated Autoimmune Myopathy
NEJM 381:275-283, Case 22-2019, 2019
Targeting Calcitonin Gene-Related Peptide: A New Era in Migraine Therapy
Lancet 394:1765-1774, Charles, A. & Pozo-Rosich, P., 2019
Ubrogepant for the Treatment of Migraine
NEJM 381:2230-2241, Dodick, D.W.,et al, 2019
Neonatal Abstinence Syndrome
JAMA 319:1362-1374, Wachman, E.,et al, 2018
A young woman with symmetric weakness and behavioral disturbance
Neurol 90:e1442-e1447, Rosenberg, J.,et al, 2018
Preventive Migraine Drug Approved
JAMA 320:1746, , 2018
Efficacy and Tolerability of Erenumab in Patients with Episodic Migraine in Whom Two-of-Four Previous Preventive Treatments were Unsuccessful: A Randomised, Double-Blind, Placebo-Controlled, Phase 3b Study
Lancet 392:2280-2287,2241, Reuter, U.,et al, 2018
Galcanezumab in Chronic Migraine
Neurol 91:e2211-e2221, Detke, H.C.,et al, 2018
Non-Specific Low Back Pain
Lancet 389:736-747, Maher, C.,et al, 2017
Association of Spinal Manipulative Therapy with Clinical Benefit and Harm for Acute Low Back Pain
JAMA 317:1451-1460,1418, Paige, N.M.,et al, 2017
Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome
NEJM 376:2341-2348, Kraft, W.K.,et al, 2017
CGRP - The Next Frontier for Migraine
NEJM 377:2190-2191, Hershey, A.D., 2017
Neonatal Abstinence Syndrome
NEJM 375:2468-2479, McQueen, K. & Murphy-Oikonen, J., 2016
Opioids for Low Back Pain
BMJ 350:g6380, Deyo, R.A.,et al, 2015
Fibromyalgia
BMJ 345:g1224, Rahman, A.,et al, 2014
Disorders of the Nervous System Caused by Drugs, Toxins, and Chemical Agents, Opiates and Synthetic Analgesic Drugs
Adams & Victors Principles of Neurology Chp 43, pg 1201, Ropper, A.H.,et al, 2014
Aspergillus Meningitis: A Rare Clinical Manifestation of Central Nervous System Aspergillosis
J Infect 66:218-238, Antinori, S.,et al, 2013
New Drugs in Migraine Treatment and Prophylaxis: Telcagepant and Topiramate
Lancet 376:645-655, Edvinsson,L. &Linde,M., 2010
Morphine, Gabapentin, or Their Combination for Neuropathic Pain
NEJM 352:1324-1334, 1373, Gilron,I.,et al, 2005
Terminating Migraine with Allodynia and Ongoing Central Sensitization Using Parenteral Administration of COX1/COX2 Inhibitors
Headache 45:850-861, Jakubowski,M.,et al, 2005
Use of Narcotic Analgesics in the Emergency Department Treatment of Migraine Headache
Neurol 62:1695-1700,1662, Colman,I.,et al, 2004
Daily Scheduled Opioids for Intractable Head Pain
Neurol 62:1687-1694,1662, Saper,J.R.,et al, 2004
Practice Parameter: Treatment of Postherpetic Neuralgia
Neurol 63:959-965, Dubinsky,R.M.,et al, 2004
Oral Opioid Therapy for Chronic Peripheral and Central Neuropathic Pain
NEJM 348:1223-1232, 1279, Rowbotham,M.C.,et al, 2003
Management of Drug and Alcohol Withdrawal
NEJM 348:1786-1795, Kosten,T.R. &O'Connor,P.G., 2003
Treatment of Herpes Zoster and Postherpetic Neuralgia
BMJ 326:748-750, Johnson,R.W. &Dworkin,R.H., 2003
Advances in Neuropathic Pain
Arch Neurol 60:1524-1534, Dworkin,R.H.,et al, 2003
Opioids Versus Antidepressants in Postherpetic Neuralgia
Neurol 59:1015-1021, Raja,S.N.,et al, 2002
Long-Term Follow-Up on Restless Legs Syndrome Patients Treated with Opioids
Mov Disord 16:1105-1109, Walters,A.S.,et al, 2001
Efficacy of Oxycodone in Neuropathic Pain, A Randomized Trial in Postherpetic Neuralgia
Neurol 50:1837-1841, Watson,C.P.N.&Babul,N., 1998
Chronic Neutrophilic Meningitis Caused by Candida Albicans
Neurologia 13:362-366, del Pozo, M.M.,et al, 1998
Gluteal Compartment Syndrome Due to Rhabdomyolysis After Heroin Abuse
Neurol 48:275-276, Klockgether,T.,et al, 1997
Randomised Double-Blind Trial of Intravenous Fentanyl in Neuropathic Pain
Lancet 349:753-758, Dellemijn,P.L.I.&Vanneste,J.A.L., 1997
Palliative Care in Neurology
Neurol 46:870-872, 5981996., Bernat,J.L.,et al, 1996